Roche Gs (ROG)

Sector:

Medicine and Biotech Research

Index:

Swiss Market Index

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

Sf 152.40
   
  • 52 Week High: Sf168.70
  • 52 Week Low: Sf117.00
  • Currency: Swiss Francs
  • Shares Issued: 160.00m
  • Market Cap: Sf24,384m

Roche Gs Overview

Roche is a healthcare company. The group is active in the discovery and development, manufacturing and marketing of pharmaceutical products.

3 Month Chart (25-05-2012)

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 4.5%
Div Cover 1.8
Op Mrgn 31.6%
ROCE 41.9%
Latest F'cast
P/E 12.4
PEG n/a
Pr/Revenue 0.6
Pr/Book 1.7
Latest F'cast
Revenue -10.4%
PBT 6.0%
EPS -3.8%
DPS 3.0%

Roche Gs Fundamentals

Year Ending Revenue (Sfm) Pre-tax (Sfm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 46,133.00 15,304.00 12.06Sf n/a n/a +22% 4.60 0.0%
31-Dec-08 45,617.00 14,161.00 10.28Sf 15.8 n/a -15% 5.00 3.1%
31-Dec-09 49,051.00 10,232.00 12.34Sf 14.2 0.7 +20% 6.00 3.4%
31-Dec-10 47,473.00 11,211.00 12.78Sf 10.7 2.7 +4% 6.60 4.8%
31-Dec-11 42,531.00 11,885.00 12.30Sf 12.9 n/a -4% 6.80 4.3%

Roche Gs Forecasts

Year Ending Revenue (Sfm) Pre-tax (Sfm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 44,662.53 14,379.01 13.53Sf 11.3 0.0 +10,903% 7.34Sf 4.8%
31-Dec-13 46,620.54 15,912.82 14.72Sf 10.4 1.2 +9% 7.99Sf 5.3%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Roche Gs Market Data

Currency Swiss Francs
% Change 0.26 %
52 Week High Sf168.70
52 Week Low Sf117.00
Shares Issued 160.00m
Market Cap Sf24,384m

What The Brokers Say

Strong Buy 17
Buy 5
Neutral 7
Sell 1
Strong Sell 0
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page